TABLE 1.
Characteristics of Study Participants at Enrolment (N = 397)
| N (%) | |
| Age (yrs) | |
| Mean (SD) | 28.2 (6.6) |
| Median (IQR) | 27 (17; 37) |
| Gestational age (wk) | |
| Mean (SD) | 18.8 (4.6) |
| Literate* | 371 (79.7) |
| Gravidity | |
| Primigravidae | 48 (12.1) |
| Multigravidae | 349 (87.9) |
| Anemia (<11 g/dL) | 195 (49.1) |
| MUAC (cm)† | |
| ≤22.0 | 8 (2.0) |
| >22.0 | 386 (97.2) |
| NI | 3 (0.8) |
| HIV VL load (copies/mm) | |
| <50 (undetectable) | 252 (63.5) |
| ≥50 | 145 (36.5) |
| ARV regimen | |
| Treatment naïve | 92 (23.4) |
| TDF + 3TC + EFV | 88 (22.4) |
| TDF + 3TC + DTG | 209 (53.2) |
| Another regimen | 4 (1.0) |
| NI | 4 (1.0) |
| Time on ARV therapy (yrs) | |
| Median (IQR) | 2.9 (−2.6; −8.4) |
| Rapid syphilis test positive | 13 (3.3) |
*
Being able to read and/or write.
†
MUAC, middle-upper arm circumference.
SD, standard deviation; IQR, interquartile range; NI, no information; TDF, tenofovir; 3TC, lamivudine; EFV, efavirenz; DTG, dolutegravir.